{
    "title": "Cancer drug 'could double life expectancy'",
    "url": "https://www.dailymail.co.uk/health/article-381921/Cancer-drug-double-life-expectancy.html",
    "date": "2006-04-04",
    "keywords": [
        "cancer",
        "breast",
        "lapatinib",
        "herceptin",
        "drug",
        "cent",
        "trial",
        "treatment",
        "disease",
        "pill",
        "brain",
        "combination",
        "her2",
        "news",
        "year",
        "uk",
        "body",
        "chemotherapy",
        "gsk",
        "type",
        "health",
        "nhs",
        "life",
        "expectancy",
        "advantage",
        "form",
        "side",
        "target",
        "progression",
        "licence",
        "rate",
        "xeloda",
        "half",
        "test",
        "remainder",
        "experiment",
        "analysis",
        "aim",
        "conference",
        "month",
        "paolo",
        "paoletti",
        "vicepresident",
        "oncology",
        "medicine",
        "development",
        "centre",
        "medication",
        "gene",
        "growth",
        "quarter",
        "risk",
        "recurrence",
        "use",
        "refusal",
        "course",
        "anticancer",
        "institute",
        "excellencebefore",
        "addition",
        "resistance",
        "kidney",
        "professor",
        "john",
        "director",
        "research",
        "precise",
        "committee",
        "dr",
        "sarah",
        "head",
        "policy",
        "information",
        "breakthrough",
        "option",
        "armoury"
    ],
    "category": [
        "health"
    ]
}